Clinical Trials Directory

Trials / Unknown

UnknownNCT02138721

Local Treatment With RP for Newly-diagnosed mPCa

Local Treatment With Radical Prostatectomy (RP) for Newly-diagnosed Metastatic Prostate Cancer (mPCa).

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
Male
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the role of local treatment with radical prostatectomy in patients with newly-diagnosed metastatic hormone-sensitive prostate cancer.

Detailed description

Patients recently diagnosed with metastatic prostate cancer (mPCa), and meeting the eligibility criteria, will be given the opportunity to enroll in this study. Study Groups: After inclusion, patients requesting local treatment can undergo radical prostatectomy (RP) with pelvic lymph-node dissection (PLND) after multi-disciplinary evaluation. This resulting in a local treatment group and a no local treatment group. For ethical reasons, no randomization will be done. Follow-up: Patients not undergoing local treatment will undergo the current standard of care in our institution. And besides the intervention of local treatment, the other patients will receive this same current standard of care. Routine follow-up visits, with physical examination, laboratory tests and questionnaires, will be scheduled every 3 months. A CT-scan (abdomen-pelvis) and bone scan will be performed if a clinical progression is diagnosed or suspected and when Castration Refractory PCa (CRPC) is established. Androgen Deprivation Therapy (ADT) will be initiated in case of one of the following: * symptoms related to metastatic lesion(s) * Prostate Specific Antigen (PSA) \> 50ng/ml and doubling time (PSA-DT) \< 6 months (starting 3 months after inclusion at earliest) The estimated number of patients to be included in the local treatment arm is 40.

Conditions

Interventions

TypeNameDescription
PROCEDURERadical Prostatectomy (RP)Radical Prostatectomy with extended Pelvic Lymph Node Dissection within 8 weeks after inclusion.

Timeline

Start date
2018-06-28
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2014-05-15
Last updated
2023-12-20

Locations

5 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02138721. Inclusion in this directory is not an endorsement.